Who is this course for?
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.
Fluence
English
Next cohort: Jun 1, 2026
150 hours
Start date: June 1, 2026
Application deadline: June 1, 2026
The Certificate in Psychedelic-Assisted Therapies and Research is a professional program from the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research. It is designed for professionals working in mental health, medicine, law, clergy, and chaplaincy roles. The curriculum includes intellectual, personal, and applied learning in psychedelic-assisted and entactogen-assisted psychotherapy research and clinical work. Topics listed on the source page include pharmacology of psychoactive substances, research design, therapist and facilitator competencies, the global history of psychoactive plant use, and cultural competencies. The program emphasizes clinical work with MDMA and psilocybin, with additional coursework on ketamine-assisted psychotherapy. It is described as a hybrid course with an estimated 150 hours of workload.
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
Open to professionals in licensed mental health, medical, and legal professions, as well as ordained or commissioned clergy and chaplains.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
Open to professionals in licensed mental health, medical, and legal professions, as well as ordained or commissioned clergy and chaplains.
Format: Hybrid. Time commitment: 150 hours.
The listed price is $8,300. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-06-01. The listed application deadline is 2026-06-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By CIIS
Shares course skills and categories
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: San Francisco, United States + Online + Portland, United States
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: Online + San Francisco, United States + Portland, United States
Includes medicine self-experience